CUMBRAE OYSTERS LIMITED

Company number SC157761 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: Cumbrae Oysters Limited

1. Financial Health Score: A-

Explanation: Cumbrae Oysters Limited presents as a robust, well-capitalised business with an exceptionally strong balance sheet. The company has demonstrated consistent net asset growth over the past decade, maintains minimal leverage, and possesses liquid resources well in excess of near-term obligations. The slight reservation from an "A" grade reflects the significant cash reduction in the latest year and the concentration of value in biological stock, which carries inherent risks in aquaculture.


2. Key Vital Signs

Vital Sign 2026 2025 Interpretation
Net Assets £596,521 £538,137 ✅ Healthy growth of 10.8% - strong heartbeat
Current Ratio 8.2:1 5.3:1 ✅ Excellent liquidity - robust immune system
Cash £104,779 £200,782 ⚠️ 48% decrease - needs monitoring
Stock £265,100 £149,186 ⚠️ 78% increase - significant inventory build
Total Liabilities £68,852 £108,933 ✅ 37% reduction - debt burden easing
Retained Earnings £569,521 £511,137 ✅ £58,384 added - accumulating reserves
Long-term Debt £0 £2,500 ✅ Fully cleared - excellent
Employees 8 12 ⚠️ 33% reduction - investigate cause

Long-term Growth Trajectory

The patient's medical history shows remarkable vitality:

Year Net Assets Year-on-Year Growth
2017 £164,875
2018 £205,707 +24.8%
2019 £230,968 +12.3%
2020 £280,933 +21.6%
2021 £360,631 +28.4%
2022 £402,422 +11.6%
2023 £528,494 +31.3%
2024 £496,007 -6.1% ⚠️
2025 £538,137 +8.5%
2026 £596,521 +10.8%

Net asset growth over 9 years: +262% — from £164,875 to £596,521


3. Diagnosis

Overall Condition: Healthy with Minor Symptoms Requiring Monitoring

The financial data reveals a business in excellent constitutional health, though displaying some symptoms that warrant closer examination:

Strengths — The Healthy Signs

Strong Balance Sheet Immunity: With net assets of nearly £600,000 and no long-term debt, this business has substantial reserves to withstand economic shocks. Think of this as a patient with excellent cardiovascular fitness and a robust immune system.

Conservative Leverage: Total liabilities of just £68,85252 represent only 11.5% of net assets. The debt-to-equity ratio of 0.12:1 is exceptionally low — this business is not over-leveraged and has significant borrowing capacity should opportunities arise.

Growing Retained Earnings: The accumulated profit reserve has grown from £164,875 in 2017 to £569,521 in 2026. This demonstrates sustained profitability over many years — the business is not living beyond its means.

Eliminated Long-term Debt: The £2,500 long-term loan from 2025 has been fully repaid. The company now has zero long-term liabilities.

Improved Trade Creditor Position: Trade creditors reduced from £64,902 to £41,454, suggesting either improved cash flow management or renegotiated supplier terms.

Symptoms Requiring Attention

Cash Compression: Cash at bank fell by £95,923 (48%) from £200,782 to £104,779. While still a healthy absolute figure, the rate of decline bears monitoring. The cash has been deployed into: - Increased stock (+£115,914) - Fixed asset additions (£51,436) - Debt repayments

This is not necessarily concerning — it represents active reinvestment — but the cash conversion cycle deserves attention.

Stock Concentration Risk: At £265,100, stock now represents 47% of current assets and 44% of total assets. As a marine aquaculture business, this stock comprises live oysters at various growth stages. This creates biological risk exposure: - Mortality events (disease, adverse weather, water quality issues) - Market price fluctuations - Predation or environmental damage

The accounting policy notes that stock is valued at the lower of cost and net realisable value, accounting for estimated mortality rates and production costs — this is appropriate and prudent.

Trade Debtors: At £175,037, trade debtors remain significant. While reduced from £205,922, this still represents approximately 3-4 months of apparent turnover (based on retained earnings growth as a proxy). Collection efficiency should be monitored.

Employee Reduction: Average employees dropped from 12 to 8 — a 33% decrease. This could indicate: - Seasonal adjustment - Operational efficiency improvements - Cost reduction measures - Potential capacity constraints

Without turnover data (filed as "Total Exemption Full" — income statement not delivered), the impact on productive capacity is unclear.

What the Numbers Don't Tell Us

As a small company filing under the small companies regime, Cumbrae Oysters is not required to file its Profit & Loss account. This means we cannot directly observe: - Turnover/revenue figures - Gross or net profit margins - Operating costs breakdown - Profitability trends

However, the retained earnings increase of £58,384 (from £511,137 to £569,521) provides a minimum profit proxy, though this is after any dividends or drawings.


4. Prognosis

Future Financial Outlook: Favourable

The prognosis for Cumbrae Oysters Limited is positive, based on:

  • Sustained Growth Trajectory: Nine consecutive years of net asset growth (with one minor dip in 2024) demonstrates resilience and effective management
  • Minimal Financial Obligations: With no long-term debt and current liabilities well-covered, the business has financial flexibility
  • Reinvestment in Assets: The £51,436 in fixed asset additions during 2026 suggests continued investment in productive capacity
  • Established Market Position: Operating since 1995 with a name change in 2002 (from Marlin Diving and Watersports to Cumbrae Oysters), the business has pivoted successfully and built longevity

Key Risks to Monitor: - Aquaculture-specific risks (environmental, biological, regulatory) - Cash flow management as stock levels grow - Concentration of ownership (single PSC/director) - Potential working capital pressure if stock doesn't convert to cash efficiently


5. Recommendations

Immediate Actions

  1. Monitor Cash Conversion Cycle: With stock at £265,100 and cash at £104,779, establish clear timelines for stock-to-cash conversion. Set cash floor targets to ensure operational flexibility.

  2. Stock Risk Assessment: Given the biological nature of oyster stock, consider: - Regular mortality monitoring and documentation - Insurance coverage for catastrophic stock loss - Diversification of growing areas or species to mitigate concentration risk

  3. Trade Debtor Management: With £175,037 outstanding, review: - Average collection periods - Credit terms offered to customers - Whether debtor levels are appropriate for the business size

Medium-term Considerations

  1. Succession Planning: As a single-director, single-PSC company, the business is entirely dependent on Mr. Forbes. Consider: - Key person insurance - Documenting operational procedures - Succession or exit planning

  2. Strategic Cash Deployment: With net current assets of £495,590 and zero long-term debt, the business has significant financial capacity. Consider whether excess capital could be better deployed through: - Further business investment - Diversification - Pension contributions (noted as defined contribution scheme in operation) - Distribution to shareholders

  3. Employee Strategy: Clarify whether the reduction from 12 to 8 employees is permanent or seasonal. If permanent, ensure capacity exists for growth and that knowledge hasn't been lost.

Ongoing Monitoring

  1. Track the Cash-to-Stock Ratio: A healthy aquaculture business should maintain sufficient cash reserves relative to stock value. Consider a target ratio of cash ≥ 40% of stock value.

  2. Annual Financial Health Check: Continue monitoring the trends identified in this assessment, particularly: - Net asset growth rate - Current ratio maintenance (currently excellent at 8.2:1) - Stock-to-cash conversion efficiency - Retained earnings trajectory


Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 6 August 2026